Contact
Please use this form to send email to PR contact of this press release:
FIXX DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Investors in Homology Medicines, Inc. Substantial Losses Have Opportunity to Lead Class Action Lawsuit
TO: